NCT05412784

Brief Summary

Cost-of-illness studies in palliative care (PC) are a growing area of interest in health economics activity. They are, in part, stakeholders' basis for deciding the allocation of the scarce public and private economic resources. There is no standard methodology to capture the formal and informal costs and expenses that health services and patients and their caregivers make during the PC attention period due to non-standard health services, and data capture approaches.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 9, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

March 17, 2023

Status Verified

May 1, 2022

Enrollment Period

9 months

First QC Date

May 31, 2022

Last Update Submit

March 16, 2023

Conditions

Keywords

Palliative Care [MeSH]Cost and Cost Analysis [MeSH]Outpatients [MeSH]

Outcome Measures

Primary Outcomes (1)

  • Determination of economic burden (costs) of palliative care in the outpatient context.

    Calculation and report the economic burden (i.e., total costs) of outpatient palliative care services, medications and procedures covered and financed by the healthcare system alongside with those covered by the patients and their families/caregivers during the last six (6) months of life (in adult patients with lung, colorectal and breast neoplasms and with terminal cardiac heart failure \[CHF\] and chronic obstructive pulmonary disease \[COPD\]).

    6 months

Secondary Outcomes (2)

  • Type of costs.

    6 months

  • Differentiate and compare costs.

    6 months -1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a history of breast, lung, and colorectal neoplasm or Chronic Heart Failure (CHF) or Chronic Obstructive Pulmonary Disease (COPD), managed in the outpatient/domiciliary scenarios and their families/caregivers.

You may qualify if:

  • Clinical diagnosis of breast, lung, and colorectal neoplasm or Chronic Heart Failure (CHF) or Chronic Obstructive Pulmonary Disease (COPD).
  • Patient and caregivers must be able to maintain a 1-hour telephonic interview.
  • Patient and caregivers must allow one (1) more telephone call to revise data.

You may not qualify if:

  • Cases with an open legal process.
  • Family/caregivers of patients that can't communicate in fluent Spanish or Catalan.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2022

First Posted

June 9, 2022

Study Start

April 1, 2023

Primary Completion

December 31, 2023

Study Completion

March 31, 2024

Last Updated

March 17, 2023

Record last verified: 2022-05